Marc Tessier-Lavigne
Co-founder, Chairman & Chief Executive Officer, Xaira Therapeutics · USA
Marc Tessier-Lavigne is the CEO of Xaira Therapeutics. Tessier-Lavigne is based in USA. Tessier-Lavigne has held the role since 2023.
Marc Trevor Tessier-Lavigne is a Canadian-American neuroscientist who is the co-founder, CEO, and chair of the AI biotechnology firm Xaira Therapeutics. He is also a biology professor at Stanford University, where he served as its 11th president from 2016 until his resignation in 2023.
Recent developments
AI summary of recent coverageRecent coverage has focused on Xaira Therapeutics' expansion of its artificial intelligence-driven drug discovery platform, including leadership team additions, the release of its first virtual cell model, and the company's nearly $1 billion fundraising round that positions it to scale its computational biology capabilities. Coverage has highlighted Marc Tessier-Lavigne's vision for using AI to accelerate drug research and the company's efforts to develop increasingly sophisticated virtual cell models as part of its approach to transforming the drug development process.
Summarized from the headlines below; see each source for the full story.
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Marc Tessier-Lavigne, it will appear here — and tie into the news timeline.
Marc Tessier-Lavigne: FAQ
- Who is Marc Tessier-Lavigne?
- Marc Tessier-Lavigne is the Co-founder, Chairman & Chief Executive Officer of Xaira Therapeutics, based in USA.
- What company does Marc Tessier-Lavigne lead?
- Marc Tessier-Lavigne is CEO of Xaira Therapeutics, a role held since 2023.